BNET Industries
Market Cap:$147.9B
Last Fiscal Year Sales:$48.4B
- Public
- US
Dow Jones Description
Taking care of you and your four-legged friends too! Pfizer Inc. (NYSE: PFE), based in New York, NY, discovers, develops, manufactures and sells prescription medications for humans and animals. Employing about 115,000 people, this $51.3 billion company operates in three segments: Human Health, Consumer Healthcare and Animal Health. Together, these segments cover treatments for diseases such as cardiovascular and metabolic diseases, medications for oral care, tobacco dependence, and products for prevention and treatment of diseases in livestock and pets.
Number of Employees 81,800
Peer Companies
NAICS Code Pharmaceutical Preparation Manufacturing: 325412
Recent Events
-
Pfizer Whistleblower Named Year's Most Influential Person In Business Ethics
-
A Dividend-Stock Holiday Shopping List
-
Week of Dec. 14, 2009: Company Notes: Sanofi Pasteur recalls H1N1 vaccine; Patheon consolidates Puerto...
-
Adimab Announces New Antibody Discovery Collaborations and Achievement of Milestones in Two...
-
Adimab Announces New Antibody Discovery Collaborations and Achievement of Milestones in Two Existing Partnerships
-
Susan Kim: Menopause: Marketing Fear
-
Takeda, Pfizer To Co-Promote Actos Type 2 Diabetes Drug In China - Update
-
Pfizer Raises Quarterly Dividend 13%, See More Annual Hikes
-
Pfizer Declares 1Q 2010 Cash Dividend
-
BRIEF: SEC probing insider-trading allegations
-
Pfizer joins partnership with Calif. firm: Collaboration planned with Crown Bioscience for cancer research
-
Research and Markets: The Future of Cardiovascular Diseases Therapeutics - Market Forecasts to...
-
Science and Technology: Pfizer to buy Croatian drug patent
-
Bristol-Myers Squibb Raises Exchange Offer Price For Mead Johnson Shares - Update
-
'IT boosts efficiency & innovation'
-
Inspector General Saved Billions in Healthcare This Year
-
Private security firms no longer able to provide police information checks
-
Reportlinker Adds Growth Factors Blood And Tissue - A World Report
News & Analysis
Filter by
finance and pfizer inc. and pharmaceutical company - All News and Analysis
Why Pfizer's Deal with Protalix Is Bad News for Big Pharma Sales Reps
BNET
- 2009-12-01
Pfizer's partnership with Protalix BioTherapeutics for Gaucher's disease drug Uplyso taliglucerase alfa offers one more piece of evidence that the days of traditional big pharma sales reps are limited. by Trista Morrison
Pharma Roundup: AstraZeneca and Teva Mend Fences, Barbara Ryan's M&A Speculation, and More
BNET
- 2008-11-25
AstraZeneca and Teva settle a potentially-acrimonious patent battle. Barbara Ryan speculates on pharma M&A. EU criticizes "strategic patenting." Indonesia wants drug production facilities from Big Pharma. by John Maas
Pharma's Deal-Making Frenzy: Lots of Noise, Less Substance
BNET
- 2008-09-11
Reading the mainstream press over the last few weeks could give you the strong impression that pharma has entered a phase of deal-making frenzy. Here's how Reuters describes it today: Big pharmaceutical companies are set to step up the hunt for assets to buy in promising fields like biotechnology,...
Pills popping up; Pharmaceutical shares; The rise of pharmaceutical stocks.(Finance and Economics)(growing value of Pfizer, and other pharmaceutical firms)(Brief Article)
- 2001-04-07
THE very biggest companies in America have always reflected the nature of the American economy itself. At the beginning of the 20th century, it was railroad firms that had the largest stockmarket value. Then it was steel; then cars; and then energy. THE very biggest...
- 1
Industry Transcripts by Seeking Alpha
-
Schiff Nutrition International, Inc. F2Q10 (Qtr End 11/30/09) Earnings Call Transcript
on Dec 17, 2009about WNI
-
Martek Biosciences Corporation F4Q09 (Qtr End 10/31/09) Earnings Call Transcript
on Dec 16, 2009about MATK
-
Peregrine Pharmaceuticals Inc. F2Q10 (Qtr End 31/10/09) Earnings Call Transcript
on Dec 10, 2009about PPHM
-
Avanir Pharmaceuticals F4Q09 (Qtr End 09/30/2009) Earnings Call Transcript
on Nov 24, 2009about AVNR
-
Palatin Technologies F1Q10 (Qtr End 9/30/09) Earnings Call Transcript
on Nov 16, 2009about PTN
IndustryTop Rated
- How NOT to Write a Biotech Press Release: Just Ask Epeius 5 votes
- Teva, In Turnabout, Sues to Protect Its Multiple Sclerosis Drug Copaxone 3 votes
- VeriChip TV Ad Confirms Critics' Fears: They Want Everyone Implanted 3 votes
- Biogen Idec's Social Media Ties Save Tysabri Again; FDA Watching 3 votes
- BioCryst's Antiviral Drug Peramivir Aims to Keep Swine-Flu Body Count Low 3 votes
Presented by American Express